Skip to content
Bamboo Works
Search
Sign in / Register
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • 繁中
  • Eng
  • 简中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

drug

FAST NEWS: Kintor Pharma Strapped for Cash as Loss Widens

The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Wednesday it did not record any revenue in the first half of the year, as its net loss widened to 518 million yuan ($75…
August 30, 2022

FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying

The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced late Wednesday that executive director Tang Renhong has been appointed as Co-CEO and will assist Chairman and CEO Ren Jinsheng in leading…
May 26, 2022

I-Mab Shaken by Management Moves, Merger Talk and Delisting Threat

Cancer drug maker has been in a wide range of market-moving headlines lately, though its stock still trades near an all-time low Key Takeaways: I-Mab was placed on a list…
May 6, 2022

FAST NEWS: InnoCare Pharma Sees Losses Shrinking, But Stock Still Slumps

The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday evening that it expects to report a net loss of up to 100 million yuan ($15.7 million) for all 2021,…
February 24, 2022

FAST NEWS: Legend Biotech Halts Trials for LB1901 CAR-T Therapy Drug

The latest: Legend Biotech Corp. (LEGN.US) announced that the Phase 1 clinical trial for its LB1901 drug has been put on hold. LB1901 is the company’s autologous chimeric antigen receptor…
February 16, 2022

I-Mab Founder Retakes Reins in Latest Shakeup Ahead of Commercialization Phase

Drug maker announces latest senior appointments as investors anticipate regulatory approval for some of its products as early as 2023 Key takeaways Four-year company veteran and CEO Joan Shen to…
December 30, 2021

Kintor Pharma Gets Mega-Booster from Experimental Covid-19 Drug

Company posted major milestone last week with the first emergency use authorization for its drug Proxalutamide to treat the coronavirus in Paraguay Key points:  Kintor Pharma’s Proxalutamide could become a…
July 22, 2021
Load more

Recent Articles

August 30, 2022

FAST NEWS: Kintor Pharma Strapped for Cash as Loss Widens

May 26, 2022

FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying

May 6, 2022

I-Mab Shaken by Management Moves, Merger Talk and Delisting Threat

February 24, 2022

FAST NEWS: InnoCare Pharma Sees Losses Shrinking, But Stock Still Slumps

February 16, 2022

FAST NEWS: Legend Biotech Halts Trials for LB1901 CAR-T Therapy Drug

December 30, 2021

I-Mab Founder Retakes Reins in Latest Shakeup Ahead of Commercialization Phase

July 22, 2021

Kintor Pharma Gets Mega-Booster from Experimental Covid-19 Drug

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

Bamboo Works offers a range of partnerships for corporate and other partners, including opportunities for sponsored content, article-writing services and a wide range of promotions.

About Us
Focus Companies
Fast News
Expert Corner
Premium Content
Facebook Twitter Linkedin Weixin Weibo File-alt

Categories

  • Healthcare/biotech
  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce

Newsletter

For all latest news, offers and special announcements.
Subscribe
Copyright © 2022 Bamboo Works. All rights reserved.